Sorrento Therapeutics Inc - Company Profile
Powered by 
All the data and insights you need on Sorrento Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Sorrento Therapeutics Inc Strategy Report
- Understand Sorrento Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Sorrento Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP3851153B1 | Grant | MIKRONADEL-ARRAY-ANORDNUNG UND ARZNEIMITTELABGABEVORRICHTUNG | A61K9/0021; A61M2037/0023; A61M2037/0038; A61M2037/0061; A61M37/0015 | September 21, 2022 |
| WO2022192594A2 | Application | NUCLEIC ACID MOLECULES AND VACCINES COMPRISING SAME FOR THE PREVENTION AND TREATMENT OF CORONAVIRUS INFECTIONS AND DISEASE | A61K2039/53; A61K2039/54; A61K2039/55555; A61K2039/57; A61K2039/575; A61K2039/70; A61K39/12; A61P31/14; C12N2770/20034 | September 15, 2022 |
| EP3898991A4 | Search Report | PERINEURALE VERABREICHUNG VON RESINIFERATOXIN ZUR BEHANDLUNG VON MALADAPTIVEM SCHMERZ | A61K31/357; A61K47/02; A61K47/10; A61K47/26; A61K47/36; A61K9/0019; A61P25/00; A61P25/02; A61P25/04; A61P29/02; C12N15/82 | September 14, 2022 |
| WO2022184082A1 | Application | ANTIBODY-DRUG CONJUGATES COMPRISING AN ANTI-BCMA ANTIBODY | A61K47/6803; A61K47/6849; A61K47/6867 | September 09, 2022 |
| JP2022132491A | Application | 流体送達装置用のアプリケーション装置及びその使用方法 | A61K9/0021; A61M2005/1586; A61M2037/0023; A61M2037/003; A61M2037/0061; A61M37/0015; A61M5/158; A61M5/16877 | September 08, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer